The Mammographic Correlations with Basal-Like Phenotype of Invasive Breast Cancer

Academic Radiology

Volumn 17, Issue 3, 2010, Pages 333-339

  Wang, Xiao ^a   Chao, Lan ^b   Chen, Liansheng ^a   Ma, Guohui ^a   Jin, Guangchao ^a   Hua, Mei ^a   Zhou, Gengyin ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

architectural distortion; basal like phenotype; breast cancer; Mammography; mass

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST CARCINOMA; CANCER INVASION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, BASAL CELL; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 75749092549     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.10.011     Document Type: Article

References (30)

1. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100 (2003) 8418-8423
2. Livasy C.A., Karaca G., Nanda R., et al. Phenotype evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 19 (2006) 264-271
3. Karamouzis M.V., Likaki-Karatza E., Ravazoula P., et al. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer 102 (2002) 86-90
4. Evans A.J., Pinder S.E., Ellis I.O., et al. Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Clin Radiol 49 (1994) 559-562
5. Seo B.K., Pisano E.D., Kuzimak C.M., et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol 13 (2006) 1211-1218
6. Wang X., Chao L., Chen L., et al. Correlation of mammographic calcifications with HER-2/neu overexpression in primary breast carcinomas. J Digit Imaging 21 (2008) 170-176
7. Likaki-Karatza E., Ravazoula P., Androutsopoulos G., et al. Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas. Eur J Gynaecol Oncol 27 (2006) 39-41
8. Ildefonso C., Vazquez J., Guinea O., et al. The mammographic appearance of breast carcinomas of invasive ductal type: relationship with clinicopathological parameters, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol 136 (2008) 224-231
9. Luck A.A., Evans A.J., James J.J., et al. Breast carcinoma with basal phenotype: mammographic findings. AJR Am J Roentgenol 191 (2008) 346-351
10. Yang W.T., Dryden M., Broglio K., et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 111 (2008) 405-410
11. Le Doussal V., Tubiana-Hulin M., Friedman S., et al. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): an improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64 (1989) 1914-1921
12. Greene F.I., Page D.I., and Fleming I.D. AJCC cancer staging manual. 6th ed. (2002), Springer, New York
13. Obenauer S., Hermann K.P., and Grabbe E. Applications and literature review of the BI-RADS classification. Eur Radiol 15 (2005) 1027-1036
14. American College of Radiology. Breast imaging reporting and data system (BI-RADS). 4th ed. (2003), American College of Radiology, Reston, VA
15. Cheang M.C., Voduc D., Bajdik C., et al. Basal-like breast cancer defined by 5 biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14 (2008) 1368-1376
16. Nielsen T.O., Hsu F.D., Jensen K., et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10 (2004) 5367-5374
17. Carey L.A., Perou C.M., Livasy C.A., et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295 (2006) 2492-2502
18. Bertucci F., Finetti P., Cervera N., et al. How basal are triple-negative breast cancers?. Int J Cancer 123 (2008) 236-240
19. Bidard F.C., Conforti R., Boulet T., et al. Does triple negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers. Ann Oncol 18 (2007) 1285-1286
20. Tan D.S., Marchio C., Jones R.L., et al. Triple negative breast cancer molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat 111 (2008) 27-44
21. Bauer K.R., Brown M., Cress R.D., et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109 (2007) 1721-1728
22. Dent R., Trudeau M., Pritchard K.I., et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13 (2007) 4429-4434
23. Brown M., Tsodikov A., Bauer K.R., et al. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. Cancer 112 (2008) 737-747
24. Lund M.J., Butler E.N., Bumpers H.L., et al. High prevalence of triple-negative tumors in an urban cancer center. Cancer 113 (2008) 608-615
25. Rakha E.A., El-Rehim D.A., Paish C., et al. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Eur J Cancer 42 (2006) 3149-3156
26. Tabar L., Chen H.-H., Duffy S.W., et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet 355 (2000) 429-433
27. Thurfjell E., Thurfjell M.G., and Lindgren A. Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat 67 (2001) 177-180
28. Broeders M.M., Onland-Moret N.C., Rijken H.M., et al. Use of previous screening mammograms to identify features indicating cases that would have a possible gain in prognosis following earlier detection. Eur J Cancer 39 (2003) 1770-1775
29. Yankaskas B.C., Schell M.J., Bird R.E., et al. Reassessment of breast cancers missed during routine screening mammography: a community-based study. Am J Roentgenol 177 (2001) 535-541
30. Venkatesan A., Chu P., Kerlikowske K., et al. Positive predictive value of specific mammographic findings according to reader and patient variables. Radiology 250 (2009) 648-657